| ★ |  3rd ERN ReCONNET Sharing Good Practice 2025 Event | | 84 | — | |
| 3 |  Hydroxychloroquine in connective tissue diseases: benefits and controversial aspects | | 1.8K | — | 89 |
| 1 |  ERN ReCONNET: the New 2026 Webinar Series | | 630 | — | 91 |
| 17 |  What is the added value of triple therapy in lupus nephritis? | | 438 | — | 87 |
| 4 |  Quality of life in Relapsing Polychondritis (RP) | | 412 | — | 89 |
| 2 |  ERN ReCONNET video to launch the RARE DISEASES AWARENESS MONTH 2024! | | 360 | — | 90 |
| 16 |  How to explain the antiphospholipid profile to my patients? | | 300 | — | 87 |
| 8 |  Treatment of systemic sclerosis-associated interstitial lung disease: where do we stand in 2025? | | 285 | — | 88 |
| 20 |  Partage et valorisation des données dans les maladies rares : défis et perspectives européennes | AP-HP, Assistance Publique - Hôpitaux de Paris @aphphopitauxdeparis | 165 | Francia | 87 |
| 11 |  ERN ReCONNET New Sjögren’s Syndrome (SS) Disease Coordinator: Prof. Gaetane Nocturne (EN) | | 133 | — | 88 |
| 10 |  ERN ReCONNET New Ehlers-Danlos syndromes (EDS) Disease Coordinator: Dr. Marco Castori (IT) | | 123 | — | 88 |
| 9 |  ERN ReCONNET New Ehlers-Danlos syndromes (EDS) Disease Coordinator: Dr. Marco Castori (EN) | | 105 | — | 88 |
| 15 |  Vaccination in undifferentiated connective tissue disease (UCTD) | | 103 | — | 87 |
| 12 |  ERN ReCONNET New Sjögren’s Syndrome (SS) Disease Coordinator: Prof. Gaetane Nocturne (FR) | | 99 | — | 88 |
| 13 |  Osteoporosis in rare and complex connective tissue diseases | | 96 | — | 88 |
| 19 |  Rede Europeia de Referência - European Reference Network (ERN) ReCONNET National Hub - Portugal | | 90 | — | 87 |
| 14 |  ERN ReCONNET ePAG Olga Drápalová: A message for the World Myositis Day, Sept. 21st | | 86 | — | 87 |
| 7 |  Chat-GPT and more – how AI will revolutionize medicine and the management of rare diseases | | 71 | — | 88 |
| 6 |  Multidisciplinary diagnosis and team treatment in Idiopathic Inflammatory Myopathies | | 64 | — | 89 |
| 18 |  The new Clinical Patient Management System 2.0 - Virtual consultations across borders | | 37 | — | 87 |
| 5 |  Genetic Testing in the Era of NGS: Lessons from the Hereditary Connective Tissue Disorders | | 35 | — | 89 |